Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a study of JTE-451 ointment in plaque psoriasis
jRCT2031210232Phase 2Completed
- Sponsor
- Japan Tobacco
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in plaque psoriasis comparing JTE-451 ointment with Placebo ointment (2 arms). Primary endpoint: PASI 75 response rate. Started Aug 2021; status: completed.
02
Drugs
JTE-451
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on jRCT2031210232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210232.